| Title : Serum paraoxonase (PON1) isozymes: the quantitative analysis of isozymes affecting individual sensitivity to environmental chemicals - La_2001_Drug.Metab.Dispos_29_566 |
| Author(s) : La Du BN , Billecke S , Hsu C , Haley RW , Broomfield CA |
| Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 29 :566 , 2001 |
| Abstract : |
| PubMedSearch : La_2001_Drug.Metab.Dispos_29_566 |
| PubMedID: 11259353 |
| Title : Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters - Billecke_2000_Drug.Metab.Dispos_28_1335 |
| Author(s) : Billecke S , Draganov D , Counsell R , Stetson P , Watson C , Hsu C , La Du BN |
| Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 28 :1335 , 2000 |
| Abstract : |
| PubMedSearch : Billecke_2000_Drug.Metab.Dispos_28_1335 |
| PubMedID: 11038162 |
| Title : Increased plasma cholinesterase activity and mivacurium resistance: report of a family - |
| Author(s) : Naguib M , Gomaa M , Samarkandi AH , Bevan DR , Akkielah AK , Watson C , Billecke S , La Du BN |
| Ref : Anesthesia & Analgesia , 89 :1579 , 1999 |
| PubMedID: 10589654 |
| Title : Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants - Aviram_1999_Free.Radic.Biol.Med_26_892 |
| Author(s) : Aviram M , Rosenblat M , Billecke S , Erogul J , Sorenson R , Bisgaier CL , Newton RS , La Du BN |
| Ref : Free Radic Biol Med , 26 :892 , 1999 |
| Abstract : |
| PubMedSearch : Aviram_1999_Free.Radic.Biol.Med_26_892 |
| PubMedID: 10232833 |
| Title : Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase\/arylesterase - Sorenson_1999_Chem.Biol.Interact_119-120_243 |
| Author(s) : Sorenson RC , Aviram M , Bisgaier CL , Billecke S , Hsu C , La Du BN |
| Ref : Chemico-Biological Interactions , 119-120 :243 , 1999 |
| Abstract : |
| PubMedSearch : Sorenson_1999_Chem.Biol.Interact_119-120_243 |
| PubMedID: 10421458 |
| Title : On the physiological role(s) of the paraoxonases - La Du_1999_Chem.Biol.Interact_119-120_379 |
| Author(s) : La Du BN , Aviram M , Billecke S , Navab M , Primo-Parmo S , Sorenson RC , Standiford TJ |
| Ref : Chemico-Biological Interactions , 119-120 :379 , 1999 |
| Abstract : |
| PubMedSearch : La Du_1999_Chem.Biol.Interact_119-120_379 |
| PubMedID: 10421474 |
| Title : Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans - Haley_1999_Toxicol.Appl.Pharmacol_157_227 |
| Author(s) : Haley RW , Billecke S , La Du BN |
| Ref : Toxicol Appl Pharmacol , 157 :227 , 1999 |
| Abstract : |
| PubMedSearch : Haley_1999_Toxicol.Appl.Pharmacol_157_227 |
| PubMedID: 10373407 |
| Title : Human serum Paraoxonase\/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity - Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214 |
| Author(s) : Sorenson RC , Bisgaier CL , Aviram M , Hsu C , Billecke S , La Du BN |
| Ref : Arterioscler Thromb Vasc Biol , 19 :2214 , 1999 |
| Abstract : |
| PubMedSearch : Sorenson_1999_Arterioscler.Thromb.Vasc.Biol_19_2214 |
| PubMedID: 10479665 |
| Title : Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase\/paraoxonase activities: selective action of human paraoxonase allozymes Q and R - Aviram_1998_Arterioscler.Thromb.Vasc.Biol_18_1617 |
| Author(s) : Aviram M , Billecke S , Sorenson R , Bisgaier C , Newton R , Rosenblat M , Erogul J , Hsu C , Dunlop C , La Du BN |
| Ref : Arterioscler Thromb Vasc Biol , 18 :1617 , 1998 |
| Abstract : |
| PubMedSearch : Aviram_1998_Arterioscler.Thromb.Vasc.Biol_18_1617 |
| PubMedID: 9763535 |